Key result
This review summarizes the generation, characteristics, and therapeutic potential of procoagulant platelets in preventing adverse effects associated with current antiplatelet therapies.
Procoagulant platelets represent a distinct subpopulation that bridges primary and secondary hemostasis, offering a potential novel therapeutic target for antiplatelet therapy.
No takes yet. Share an insight, caveat, or question.
May mitigate bleeding risks from current antiplatelet therapies; leaves open whether targeting procoagulant platelets improves outcomes.
Chu et al. (2021) reported a review. Procoagulant platelets was evaluated. This review summarizes the generation, characteristics, and therapeutic potential of procoagulant platelets in preventing adverse effects associated with current antiplatelet therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: